(Q46339580)

21 December 2017

title

Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation (English)

1 reference

21 December 2017

osteoporosis-pseudoglioma syndrome

main subject

osteoporosis

0 references

1 reference

based on heuristic

inferred from title

author name string

Elizabete Ribeiro Barros

1

1 reference

21 December 2017

Magnus R Dias da Silva

2

1 reference

21 December 2017

Ilda S Kunii

3

1 reference

21 December 2017

Marise Lazaretti-Castro

4

1 reference

21 December 2017

publication date

1 August 2008

1 reference

21 December 2017

Journal of Pediatric Endocrinology and Metabolism

published in

1 reference

21 December 2017

volume

21

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

811-818

1 reference

21 December 2017

Wnt signaling in osteoblasts and bone diseases

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Clinical and molecular findings in osteoporosis-pseudoglioma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

The use of pamidronate in three children with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Cloning of a novel member of the low-density lipoprotein receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.8.811

10.1515/JPEM.2008.21.8.811

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017